EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of dose heterogeneity on response and toxicity after 90Y-SIRT for HCC

Huan Xi, Xinlin Zheng, Andor W J M Glaudemans, Joyce van Sluis, Simeon J S Ruiter, Robbert J de Haas, G Matthijs Kater, Oleksandra V Ivashchenko, Walter Noordzij

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-026-08064-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Huan Xi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands. h.xi@…. Hauptthemen laut MEDLINE: Yttrium Radioisotopes, Carcinoma, Hepatocellular, Liver Neoplasms, Radiation Dosage. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Yttrium-90 ( 90 Y) selective internal radiation therapy (SIRT) is an established treatment for hepatocellular carcinoma (HCC), yet dose-response relationships remain incompletely understood. We evaluated whether voxel-based dose heterogeneity is associated with tumour response and treatment-related toxicity.

Methods

This retrospective study included 45 HCC patients with 68 lesions treated with 90 Y resin SIRT. Dose distributions were derived from post-therapy 90 Y PET/CT. DVH-based metrics included hot-spot (D2, D10, Dmax), cold-spot (D90, D98, Dmin), and coverage parameters (V100, V150, V200). Tumour response was assessed using mRECIST. Grade ≥ 3 toxicity was classified as acute or latent. Lesions were stratified by median absorbed dose (D50 < 128 Gy vs. ≥ 128 Gy).

Results

Of 68 lesions, 44% achieved complete response. D50 did not differ significantly across mRECIST response categories. In low-D50 lesions, higher heterogeneity was associated with improved response. Hot-spot metrics (D2, D10, Dmax) showed similar trends. In high-D50 lesions, cold-spot metrics (D90, D98) were significantly associated with better response. Mean non-tumoral liver dose was associated with acute toxicity, while dose heterogeneity was associated with latent toxicity.

Conclusion

Spatial dose distribution influences outcomes beyond mean absorbed dose. Tumour response was related to a dose level dependent pattern, with hot-spot–driven heterogeneity associated with response at lower dose levels and cold-spot metrics more relevant at higher dose levels. In addition, a temporal dissociation in toxicity was identified, with mean non-tumoral liver dose associated with acute injury and spatial dose heterogeneity associated with latent severe toxicity, supporting further evaluation of spatial dosimetry for individualized SIRT planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Yttrium RadioisotopesCarcinoma, HepatocellularLiver NeoplasmsRadiation DosageHumansRetrospective StudiesFemaleMaleRadiotherapy DosageAgedDose-Response Relationship, RadiationMiddle AgedTreatment Effect HeterogeneityPositron Emission Tomography Computed TomographyTreatment OutcomeRadioembolization, Therapeutic

Stichwörter der Autor:innen

Dose heterogeneityHepatocellular carcinomaSelective internal radiation therapyVoxel-based dosimetryYttrium-90

Substanzen

Yttrium RadioisotopesYttrium-90

Autor:innen und Institutionen

  • Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands. h.xi@umcg.nl.
  • Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • Department of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • Department of Radiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.

Zitieren

APA

Xi, H., Zheng, X., Glaudemans, A. W. J. M., van Sluis, J., Ruiter, S. J. S., de Haas, R. J., Kater, G. M., Ivashchenko, O. V., & Noordzij, W. (2026). Effects of dose heterogeneity on response and toxicity after 90Y-SIRT for HCC. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08064-1

Vancouver

Xi H, Zheng X, Glaudemans AWJM, van Sluis J, Ruiter SJS, de Haas RJ, et al. Effects of dose heterogeneity on response and toxicity after 90Y-SIRT for HCC. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-08064-1

BibTeX
@article{Xi2026,
  author = {Xi, Huan and Zheng, Xinlin and Glaudemans, Andor W J M and van Sluis, Joyce and Ruiter, Simeon J S and de Haas, Robbert J and Kater, G Matthijs and Ivashchenko, Oleksandra V and Noordzij, Walter},
  title = {Effects of dose heterogeneity on response and toxicity after 90Y-SIRT for HCC},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-026-08064-1}
}
Kostenlos starten →